Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
Clinical trial NCT01971164 · COMPLETED
Trial details
- NCT number
- NCT01971164
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.